Cargando…

Role of Valganciclovir in Children with Congenital CMV Infection: A Review of the Literature

Background: Cytomegalovirus (CMV) is the most common agent of congenital infection in humans. It is a main cause of neurodevelopmental delay and sensorineural hearing loss in infancy. Since the 2000s, a number of studies have used Valganciclovir as a therapy for children with congenital CMV infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pata, Davide, Buonsenso, Danilo, Turriziani-Colonna, Arianna, Salerno, Gilda, Scarlato, Lucia, Colussi, Lara, Ulloa-Gutierrez, Rolando, Valentini, Piero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378502/ https://www.ncbi.nlm.nih.gov/pubmed/37508743 http://dx.doi.org/10.3390/children10071246

Ejemplares similares

Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir
por: Turriziani Colonna, Arianna, et al.
Publicado: (2020)

Comparison of the Clinical and Laboratory Features of COVID and Influenza in Children
por: Pata, Davide, et al.
Publicado: (2022)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Epidemiology and risk factors of hypovitaminosis D in a cohort of internationally adopted children: a retrospective study
por: Salerno, Gilda, et al.
Publicado: (2018)

Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
por: Johansson, Inger, et al.
Publicado: (2013)

576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients
por: shi, yiyun, et al.
Publicado: (2020)

Efficacy of low-dose valganciclovir in CMV R+ lung transplant recipients: a retrospective comparative analysis
por: Hunt, Jessica, et al.
Publicado: (2021)

2646. Incidence of Myelosuppression Related to Valganciclovir Prophylaxis in Solid-Organ Transplant Recipients at High Risk of CMV Disease
por: Belga, Sara, et al.
Publicado: (2019)

Psychological Impact of the COVID-19 Pandemic on Pregnant Women
por: Buonsenso, Danilo, et al.
Publicado: (2022)

Chest Computed Tomography and Lung Ultrasound Findings in COVID-19 Pneumonia: A Pocket Review for Non-radiologists
por: Pata, Davide, et al.
Publicado: (2020)

Chest CT Scan for the Diagnosis of Pediatric Pulmonary TB: Radiological Findings and Its Diagnostic Significance
por: Buonsenso, Danilo, et al.
Publicado: (2021)

1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
por: Murtagh, Kathleen, et al.
Publicado: (2020)

1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)
por: Roumpz, Caroline G, et al.
Publicado: (2021)

1571. Cost-Effectiveness Analysis of Duration of Valganciclovir Prophylaxis Among CMV Serology Mismatched (Donor+/Recipient−) Lung Transplant Recipients
por: Tomko, Heather, et al.
Publicado: (2018)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Valganciclovir: Leucopenia: case report
Publicado: (2021)

Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients
por: Rho, Elena, et al.
Publicado: (2021)

Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
por: Gambacorta, Alessandro, et al.
Publicado: (2020)

Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience
por: Buonsenso, Danilo, et al.
Publicado: (2022)

Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome
por: Buonsenso, Danilo, et al.
Publicado: (2020)

Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak
por: Buonsenso, Danilo, et al.
Publicado: (2020)

The Relationship between COVID-19 and Innate Immunity in Children: A Review
por: Valentini, Piero, et al.
Publicado: (2021)

Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach
por: Lalagkas, Panagiotis Nikolaos, et al.
Publicado: (2023)

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
por: Ohyama, Shohei, et al.
Publicado: (2019)

Correction to: Short‑ and mid‑term multidisciplinary outcomes of newborns exposed to SARS‑CoV‑2 in utero or during the perinatal period: preliminary findings
por: Buonsenso, Danilo, et al.
Publicado: (2022)

Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings
por: Buonsenso, Danilo, et al.
Publicado: (2022)

Early neurodevelopmental outcomes in children with asymptomatic congenital CMV infection
por: Novelli, Maria, et al.
Publicado: (2022)

High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
por: Rissling, Olesja, et al.
Publicado: (2018)

COVID-19 outbreak: less stethoscope, more ultrasound
por: Buonsenso, Danilo, et al.
Publicado: (2020)

Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis
por: Kabata, Yoshiaki, et al.
Publicado: (2012)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
por: Stragliotto, Giuseppe, et al.
Publicado: (2020)

Mycophenolate-mofetil/valganciclovir: Neutropenia: case report
Publicado: (2022)

Lactoferrin as Possible Treatment for Chronic Gastrointestinal Symptoms in Children with Long COVID: Case Series and Literature Review
por: Morello, Rosa, et al.
Publicado: (2022)

Indirect effects of COVID-19 on child health care: delayed diagnosis of developmental dysplasia of the hip
por: Buonsenso, Danilo, et al.
Publicado: (2020)

Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection
por: Dobbins, G. Clement, et al.
Publicado: (2019)

Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant)
por: Morioka, Ichiro, et al.
Publicado: (2020)

Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment
por: Torii, Yuka, et al.
Publicado: (2023)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: Patil, A Jayaprakash, et al.
Publicado: (2010)

Development of an appropriate simple suspension method for valganciclovir medication
por: Masaoka, Yasuyuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96qcm1d4giume1hh1b5dodk9ld